abstract |
PROBLEM TO BE SOLVED: To provide an arvocidib phosphate prodrug having higher bioavailability as compared with an arvocidib parent compound. A compound having the following structure (I) or a stereoisomer, tautomer, or a pharmaceutically acceptable salt thereof. (One of R 1 to R 3 is -P (= O) (OH) 2 , and the other two are H, respectively.) [Selection diagram] None |